시장보고서

상품코드

1515545

바이오시뮬레이션 시장 : 제품별, 용도별, 딜리버리 모델별, 최종 용도별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Biosimulation Market, By Product, By Application, By Delivery Model, By End-use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: 2024년 06월 | 리서치사:

AnalystView Market Insights | 페이지 정보: 영문 299 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

리포트 하이라이트

바이오시뮬레이션 시장 규모는 2023년에 31억 2,520만 달러에 달하며, 2024-2032년 CAGR 17.2%로 확대

바이오시뮬레이션 시장 - 시장 역학

의약품 개발 비용 절감

바이오시뮬레이션을 통한 의약품 개발 비용 절감은 전 세계 바이오시뮬레이션 시장을 촉진하는 주요 요인입니다. 바이오시뮬레이션을 통해 제약사들은 비용과 시간이 많이 소요되는 동물 실험과 임상시험을 수행하기 전에 컴퓨터 시뮬레이션을 통해 잠재적인 의약품 후보물질을 테스트함으로써 의약품 개발의 재정적 리스크를 줄일 수 있습니다. 인실리코, 즉 컴퓨터 기반 모델링 및 시뮬레이션을 통해 연구자들은 실제 사람을 사용하지 않고도 수백만 가지의 가상 시나리오를 테스트하고, 인체 내에서 원하는 반응이 일어나도록 약물 분자를 최적화할 수 있습니다. 바이오시뮬레이션을 활용하면 비용과 시간을 크게 절약할 수 있습니다. 미국 식품의약국(FDA)에 따르면 전임상 연구를 시작한 의약품 후보물질 중 1만 건 중 1건만이 인체 시험에 진입하는 것으로 나타나 개발 중 감소율이 매우 높은 것으로 나타났습니다. 마찬가지로 Tuft Center for the Study of Medicine Development(Tuft Center for the Study of Medicine Development)는 신약 출시에 소요되는 평균 비용을 26억 달러로 추산하고 있습니다. 바이오시뮬레이션을 통해 얻을 수 있는 비용과 시간 절약은 비록 작은 금액일지라도 엄청난 비용 절감 효과를 가져다 줄 수 있습니다.

바이오시뮬레이션 시장 - 주요 인사이트

AnalystView Market Insights의 리서치 애널리스트의 분석에 따르면 세계 시장은 예측 기간(2024-2032년) 동안 매년 약 17.2%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.

제품 세분화에 따라 소프트웨어 분야가 2023년 시장을 장악했습니다.

용도별로 보면 예측 기간 중 가장 높은 CAGR을 나타낼 것으로 예상되는 분야는 신약 개발입니다.

전달 모델 세분화에 따르면 2023년 제약회사, 생명공학회사가 주요 유형으로 나타났습니다.

지역별로는 북미가 2023년 매출에서 선두를 차지했습니다.

바이오시뮬레이션 시장 - 세분화 분석 :

세계 바이오시뮬레이션 시장은 제품, 용도, 전달 모델, 최종 용도 및 지역을 기준으로 세분화됩니다.

제품은 소프트웨어 및 서비스 두 가지로 분류되며, 2023년에는 소프트웨어 카테고리가 시장을 장악할 것입니다. 이는 고유한 연구개발 수요를 충족시킬 수 있는 용도 특화 소프트웨어가 시장에 풍부하게 존재하기 때문입니다.

시장은 용도별로 의약품 개발, 신약 개발, 기타 세 가지 범주로 분류됩니다. 예측 기간 중 가장 높은 CAGR을 나타낼 것으로 예상되는 분야는 신약 개발입니다. 약물유전체학, 약리유전학 등의 분야에서 바이오시뮬레이션의 활용이 확대되면서 이 분야의 성장을 촉진하고 있으며, 2020년 2월 Certara는 실리콘 바이오사이언스(Silico Biosciences, Inc.)의 신경퇴행성 질환 연구용 모델링 및 시뮬레이션 기술 플랫폼을 인수했습니다. 시뮬레이션 기술 플랫폼을 인수했습니다. 이는 신경 퇴행성 질환 연구에서 정량적 시스템 약리학(QSP) 비즈니스 모델에 도움이 되었습니다.

바이오시뮬레이션 시장 - 지역적 인사이트

바이오시뮬레이션 시장은 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카 등 여러 지역에 분포되어 있습니다. 이 지역들은 사업 운영 국가에 따라 더 세분화되어 있습니다. 북미는 2023년 가장 높은 매출 점유율을 차지했습니다. 주요 행위자의 존재, 헬스케어의 디지털화 발전, 만성적인 건강 불안의 유병률 증가가 모두 이러한 성장에 기여하고 있습니다. 또한 환자의 높은 안전과 치료 표준을 보장하기 위한 규제 정책 시행에 있으며, 비실리콘 모델의 사용이 이 지역 시장 성장을 가속하고 있습니다.

아시아태평양은 공공 및 민간 부문의 활발한 활동과 지속적인 헬스케어 인프라 구축으로 인해 예측 기간 중 비약적인 성장이 예상됩니다. 또한 신흥 국가들의 연구개발 노력의 확대는 이 지역에 큰 경제적 잠재력을 제공할 것으로 예상됩니다.

바이오시뮬레이션 시장 : 경쟁 구도:

바이오시뮬레이션 시장 경쟁 구도에서는 여러 주요 경쟁업체들이 시장 패권을 놓고 다투고 있습니다. 미국 Certara, Dassault Systemes, Advanced Chemistry Development, Simulation Plus, Schrodinger, Inc. 등이 이 시장의 주요 기업입니다. 이 회사들은 첨단 바이오시뮬레이션 소프트웨어, 모델링 능력, 약동학 및 약력학 시뮬레이션 경험으로 잘 알려져 있습니다. 바이오시뮬레이션 시장의 경쟁을 촉진하는 경쟁 요인으로는 소프트웨어의 성능, 예측 정확도, 규제 대응, 맞춤형 의료 및 의약품 개발에 대한 수요 증가에 대한 대응력 등이 있습니다. 바이오시뮬레이션 시장 경쟁 구도는 지속적인 연구개발, 전략적 제휴, 기술 혁신에 대한 강조로 형성되고 있습니다.

서론
북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 이탈리아
- 영국
- 프랑스
- 러시아
- 네덜란드
- 스웨덴
- 폴란드
- 기타
아시아태평양(APAC)
- 개요
- 아시아태평양의 주요 제조업체
- 인도
- 중국
- 일본
- 한국
- 호주
- 태국
- 인도네시아
- 필리핀
- 기타
라틴아메리카
- 개요
- 라틴아메리카의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 터키
- 알제리
- 이집트
- 기타

제12장 주요 벤더 분석 - 바이오시뮬레이션 업계

경쟁 대시보드
기업 개요
- Certara, USA
- Dassault Systemes
- Advanced Chemistry Development
- Simulation Plus
- Schrodinger, Inc.
- Chemical Computing Group ULC
- Physiomics Plc
- Rosa &Co. LLC
- BioSimulation Consulting Inc.
- Genedata AG
- Instem Group of Companies
- PPD, Inc.
- Yokogawa Insilico Biotechnology GmbH
- Immunetrics
- Others

제13장 애널리스트의 전방위 전망

KSA 24.07.26

REPORT HIGHLIGHT

Biosimulation Market size was valued at USD 3,125.2 Million in 2023, expanding at a CAGR of 17.2% from 2024 to 2032.

Biosimulation is a mathematical simulation of a biological procedure that uses computer programs to model biological processes and systems. Model-based drug development refers to the ability to make data-driven decisions utilizing a quantitative framework throughout the drug development process. Biosimulation is a promising technology used in pharmaceutical research to improve the drug discovery and development process.

Biosimulation Market- Market Dynamics

Reduced Drug Development Costs

The reduction in drug development costs achieved through the use of biosimulation is a major factor driving the global biosimulation market. Biosimulation allows pharmaceutical companies to reduce financial risks in drug development by testing potential drug candidates using computer simulation before going on to costly and time-consuming animal and clinical studies. This in silico, or computer-based, modeling and simulation enables researchers to test millions of what-if scenarios to optimize drug molecules for desired reactions in the human body without utilizing real individuals. The cost and time savings from using biosimulation are significant. According to the United States Food and medication Administration (FDA), just one in every 10,000 medication candidates that begin preclinical research progresses to human testing, indicating a significant attrition rate during development. Similarly, the Tuft Center for the Study of Medicine Development estimates that the average cost of bringing a new medicine to market is $2.6 billion. Even a modest fraction of cost and time savings achieved through biosimulation equates to huge savings.

Biosimulation Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 17.2% over the forecast period (2024-2032)

Based on Product segmentation, The software sector dominated the market in 2023.

Based on application segmentation, Drug discovery is predicted to have the greatest CAGR during the projection period.

Based on Delivery Model segmentation, Pharmaceutical, and biotechnology companies were the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Biosimulation Market- Segmentation Analysis:

The Global Biosimulation Market is segmented based on Product, Application, Delivery Model, End-use, and Region.

The market is divided into two categories based on Product: Software and Services. The software category dominated the market in 2023. This is due to the abundance of application-specific software available in the market to meet unique research and development needs.

The market is divided into three categories based on application: Drug Development, Drug Discovery, and Others. Drug discovery is expected to have the highest CAGR over the projection period. The expanding use of biosimulation in fields such as pharmacogenomics and pharmacogenetics is helping to drive the segment's growth. Certara purchased Silico Biosciences, Inc.'s modeling and simulation technology platform designed for the research of neurodegenerative disorders in February 2020. This benefited the company's quantitative systems pharmacology (QSP) business model in its research into neurodegenerative illnesses.

Biosimulation Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America had the highest revenue share in 2023. The existence of important actors, increased healthcare digitization, and the rising prevalence of chronic health concerns all contribute to this expansion. Furthermore, the use of in-silico models in the implementation of regulatory policies to ensure high patient safety and treatment standards is helping to drive regional market growth.

The Asia Pacific region is expected to grow at an exponential rate throughout the projection period as a result of increased public and private sector activities and consistent upgrades to healthcare infrastructure. Furthermore, emerging economies' expanding R&D efforts are expected to provide major economic possibilities for the region.

Biosimulation Market- Competitive Landscape:

In the competitive landscape of the Biosimulation Market, several significant competitors compete for market domination. Certara, USA, Dassault Systemes, Advanced Chemistry Development, Simulation Plus, and Schrodinger, Inc. are some of the market segment's leading companies. These firms are well-known for their advanced biosimulation software, modeling capabilities, and experience with pharmacokinetics and pharmacodynamics simulation. Factors driving competition in the Biosimulation Market include software performance, prediction accuracy, regulatory compliance, and the ability to meet the growing need for customized medicine and drug development. The Biosimulation Market's competitive landscape is shaped by ongoing R&D, strategic collaborations, and an emphasis on technological innovation.

Recent Developments:

In January 2022, Simulation Plus collaborated with a pharmaceutical business to improve the GastroPlus Advanced Compartmental Absorption and Transit (ACAT) model in support of ongoing research programs for gastrointestinal illnesses.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BIOSIMULATION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Certara, USA

Dassault Systemes

Advanced Chemistry Development

Simulation Plus

Schrodinger, Inc.

Chemical Computing Group ULC

Physiomics Plc

Rosa & Co. LLC

BioSimulation Consulting Inc.

Genedata AG

Instem Group of Companies

PPD, Inc.

Yokogawa Insilico Biotechnology GmbH

Immunetrics

Others

GLOBAL BIOSIMULATION MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

Software
Services

GLOBAL BIOSIMULATION MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

Drug Development
Drug Discovery
Others

GLOBAL BIOSIMULATION MARKET, BY DELIVERY MODEL- MARKET ANALYSIS, 2019 - 2032

Subscription Models
Ownership Models

GLOBAL BIOSIMULATION MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032

Pharmaceutical & Biotechnology Companies
CROs
Regulatory Authorities
Academic Research Institutions

GLOBAL BIOSIMULATION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Biosimulation Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Biosimulation Market Snippet by Product
- 2.1.2. Biosimulation Market Snippet by Application
- 2.1.3. Biosimulation Market Snippet by Delivery Model
- 2.1.4. Biosimulation Market Snippet by End-use
- 2.1.5. Biosimulation Market Snippet by Country
- 2.1.6. Biosimulation Market Snippet by Region
2.2. Competitive Insights

3. Biosimulation Key Market Trends

3.1. Biosimulation Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Biosimulation Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Biosimulation Market Opportunities
3.4. Biosimulation Market Future Trends

4. Biosimulation Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Biosimulation Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Biosimulation Market Landscape

6.1. Biosimulation Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Biosimulation Market - By Product

7.1. Overview
- 7.1.1. Segment Share Analysis, By Product, 2023 & 2032 (%)
- 7.1.2. Software
- 7.1.3. Services

8. Biosimulation Market - By Application

8.1. Overview
- 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
- 8.1.2. Drug Development
- 8.1.3. Drug Discovery
- 8.1.4. Others

9. Biosimulation Market - By Delivery Model

9.1. Overview
- 9.1.1. Segment Share Analysis, By Delivery Model, 2023 & 2032 (%)
- 9.1.2. Subscription Models
- 9.1.3. Ownership Models

10. Biosimulation Market - By End-use

10.1. Overview
- 10.1.1. Segment Share Analysis, By End-use, 2023 & 2032 (%)
- 10.1.2. Pharmaceutical & Biotechnology Companies
- 10.1.3. CROs
- 10.1.4. Regulatory Authorities
- 10.1.5. Academic Research Institutions

11. Biosimulation Market- By Geography

11.1. Introduction
- 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
11.2. North America
- 11.2.1. Overview
- 11.2.2. Biosimulation Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.2.6. North America Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
- 11.2.7. North America Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 11.2.8. U.S.
  - 11.2.8.1. Overview
  - 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.8.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.2.8.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.2.8.5. U.S. Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
  - 11.2.8.6. U.S. Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 11.2.9. Canada
  - 11.2.9.1. Overview
  - 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.9.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.2.9.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.2.9.5. Canada Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
  - 11.2.9.6. Canada Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
11.3. Europe
- 11.3.1. Overview
- 11.3.2. Biosimulation Key Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.6. Europe Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
- 11.3.7. Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 11.3.8. Germany
  - 11.3.8.1. Overview
  - 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.8.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.8.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.8.5. Germany Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
  - 11.3.8.6. Germany Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 11.3.9. Italy
  - 11.3.9.1. Overview
  - 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.9.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.9.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.9.5. Italy Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
  - 11.3.9.6. Italy Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 11.3.10. United Kingdom
  - 11.3.10.1. Overview
  - 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.10.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.10.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.10.5. United Kingdom Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
  - 11.3.10.6. United Kingdom Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 11.3.11. France
  - 11.3.11.1. Overview
  - 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.11.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.11.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.11.5. France Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
  - 11.3.11.6. France Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 11.3.12. Russia
  - 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.12.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.12.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.12.4. Russia Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
  - 11.3.12.5. Russia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 11.3.13. Netherlands
  - 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.13.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.13.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.13.4. Netherlands Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
  - 11.3.13.5. Netherlands Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 11.3.14. Sweden
  - 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.14.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.14.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.14.4. Sweden Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
  - 11.3.14.5. Sweden Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 11.3.15. Poland
  - 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.15.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.15.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.15.4. Poland Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
  - 11.3.15.5. Poland Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 11.3.16. Rest of Europe
  - 11.3.16.1. Overview
  - 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.16.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.16.5. Rest of the Europe Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
  - 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. Biosimulation Key Manufacturers in Asia Pacific
- 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.6. Asia Pacific Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
- 11.4.7. Asia Pacific Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 11.4.8. India
  - 11.4.8.1. Overview
  - 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.8.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.8.5. India Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
  - 11.4.8.6. India Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 11.4.9. China
  - 11.4.9.1. Overview
  - 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.9.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.9.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.9.5. China Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
  - 11.4.9.6. China Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 11.4.10. Japan
  - 11.4.10.1. Overview
  - 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.10.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.10.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.10.5. Japan Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
  - 11.4.10.6. Japan Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 11.4.11. South Korea
  - 11.4.11.1. Overview
  - 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.11.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.11.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.11.5. South Korea Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
  - 11.4.11.6. South Korea Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 11.4.12. Australia
  - 11.4.12.1. Overview
  - 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.12.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.12.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.12.5. Australia Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
  - 11.4.12.6. Australia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 11.4.13. Thailand
  - 11.4.13.1. Overview
  - 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.13.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.13.5. Thailand Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
  - 11.4.13.6. Thailand Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 11.4.14. Indonesia
  - 11.4.14.1. Overview
  - 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.14.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.14.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.14.5. Indonesia Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
  - 11.4.14.6. Indonesia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 11.4.15. Philippines
  - 11.4.15.1. Overview
  - 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.15.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.15.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.15.5. Philippines Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
  - 11.4.15.6. Philippines Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 11.4.16. Rest of APAC
  - 11.4.16.1. Overview
  - 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.16.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.16.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.16.5. Rest of APAC Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
  - 11.4.16.6. Rest of APAC Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
11.5. Latin America
- 11.5.1. Overview
- 11.5.2. Biosimulation Key Manufacturers in Latin America
- 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.6. Latin America Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
- 11.5.7. Latin America Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 11.5.8. Brazil
  - 11.5.8.1. Overview
  - 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.8.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.5.8.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.8.5. Brazil Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
  - 11.5.8.6. Brazil Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 11.5.9. Mexico
  - 11.5.9.1. Overview
  - 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.9.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.5.9.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.9.5. Mexico Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
  - 11.5.9.6. Mexico Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 11.5.10. Argentina
  - 11.5.10.1. Overview
  - 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.10.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.5.10.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.10.5. Argentina Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
  - 11.5.10.6. Argentina Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 11.5.11. Colombia
  - 11.5.11.1. Overview
  - 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.11.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.5.11.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.11.5. Colombia Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
  - 11.5.11.6. Colombia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 11.5.12. Rest of LATAM
  - 11.5.12.1. Overview
  - 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.5.12.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.12.5. Rest of LATAM Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
  - 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa
- 11.6.1. Overview
- 11.6.2. Biosimulation Key Manufacturers in Middle East and Africa
- 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.6. Middle East and Africa Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
- 11.6.7. Middle East and Africa Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 11.6.8. Saudi Arabia
  - 11.6.8.1. Overview
  - 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.6.8.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.8.5. Saudi Arabia Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
  - 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 11.6.9. United Arab Emirates
  - 11.6.9.1. Overview
  - 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.6.9.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.9.5. United Arab Emirates Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
  - 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 11.6.10. Israel
  - 11.6.10.1. Overview
  - 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.10.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.6.10.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.10.5. Israel Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
  - 11.6.10.6. Israel Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 11.6.11. Turkey
  - 11.6.11.1. Overview
  - 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.11.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.6.11.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.11.5. Turkey Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
  - 11.6.11.6. Turkey Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 11.6.12. Algeria
  - 11.6.12.1. Overview
  - 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.12.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.6.12.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.12.5. Algeria Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
  - 11.6.12.6. Algeria Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 11.6.13. Egypt
  - 11.6.13.1. Overview
  - 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.13.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.6.13.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.13.5. Egypt Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
  - 11.6.13.6. Egypt Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 11.6.14. Rest of MEA
  - 11.6.14.1. Overview
  - 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.14.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.6.14.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.14.5. Rest of MEA Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
  - 11.6.14.6. Rest of MEA Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Biosimulation Industry

12.1. Competitive Dashboard
12.2. Company Profiles
- 12.2.1. Certara, USA
- 12.2.2. Dassault Systemes
- 12.2.3. Advanced Chemistry Development
- 12.2.4. Simulation Plus
- 12.2.5. Schrodinger, Inc.
- 12.2.6. Chemical Computing Group ULC
- 12.2.7. Physiomics Plc
- 12.2.8. Rosa & Co. LLC
- 12.2.9. BioSimulation Consulting Inc.
- 12.2.10. Genedata AG
- 12.2.11. Instem Group of Companies
- 12.2.12. PPD, Inc.
- 12.2.13. Yokogawa Insilico Biotechnology GmbH
- 12.2.14. Immunetrics
- 12.2.15. Others

13. 360 Degree Analyst View

14. Appendix

14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us